Drug-Eluting Beads Bronchial Arterial Chemoembolization in Treating Relapsed/Refractory Small Cell Lung Cancer Patients: Results from a Pilot Study

References

• Ferlay J , Shin HR , Bray F , Forman D , Mathers C , Parkin DM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer . 2010;127(12):2893–2917. doi:10.1002/ijc.25516 21351269
   PubMed Web of Science ®Google Scholar
• Siegel RL , Miller KD , Jemal A . Cancer statistics, 2018. CA Cancer J Clin . 2018;68(1):7–30. doi:10.3322/caac.21442 29313949
   PubMed Web of Science ®Google Scholar
• Kalemkerian GP . Small cell lung cancer. Semin Respir Crit Care Med . 2016;37(5):783–796. doi:10.1055/s-0036-1592116 27732999
   PubMed Web of Science ®Google Scholar
• Kalemkerian GP , Schneider BJ . Advances in small cell lung cancer. Hematol Oncol Clin North Am . 2017;31(1):143–156. doi:10.1016/j.hoc.2016.08.005 27912830
   PubMed Web of Science ®Google Scholar
• Kohara H , Tabata M , Kiura K , et al. Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line. Clin Cancer Res . 2002;8(1):287–292.11801571
   PubMed Web of Science ®Google Scholar
• Xiang H , Long L , Yao Y , Fang Z , Zhang Z , Zhang Y . CalliSpheres drug-eluting bead transcatheter arterial chemoembolization presents with better efficacy and equal safety compared to conventional TACE in treating patients with hepatocellular carcinoma. Technol Cancer Res Treat . 2019;18:1533033819830751.30862264
   PubMed Web of Science ®Google Scholar
• Sharma N , Pennell N , Nickolich M , et al. Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer. Invest New Drugs . 2014;32(2):362–368. doi:10.1007/s10637-013-0061-6 24420556
   PubMed Web of Science ®Google Scholar
• Lu HY , Wang XJ , Mao WM . Targeted therapies in small cell lung cancer. Oncol Lett . 2013;5(1):3–11.23255884
   PubMed Web of Science ®Google Scholar
• Bie Z , Li Y , Li B , Wang D , Li L , Li X . The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer. Thorac Cancer . 2019;10(9):1770–1778. doi:10.1111/1759-7714.13139 31321919
   PubMed Web of Science ®Google Scholar
• Ni JY , Sun HL , Chen YT , et al. Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety. J Cancer Res Clin Oncol . 2018;144(1):157–163. doi:10.1007/s00432-017-2530-3 28993945
   PubMed Web of Science ®Google Scholar
• Ma Y , Zhao C , Zhao H , et al. Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres((R)) microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients. Am J Transl Res . 2019;11(12):7456–7470.31934293
   PubMed Web of Science ®Google Scholar
• Wen P , Chen SD , Wang JR , Zeng YH . Comparison of treatment response and survival profiles between drug-eluting bead transarterial chemoembolization and conventional transarterial chemoembolization in Chinese hepatocellular carcinoma patients: a Prospective Cohort Study. Oncol Res . 2019;27(5):583–592. doi:10.3727/096504018X15368325811545 31053181
   PubMed Web of Science ®Google Scholar
• Song J , Chen W , Zhu X , et al. Short-term efficacy, safety, and cost-effectiveness of transarterial chemoembolization with drug-eluting beads versus synchronous radiochemotherapy for cervical cancer. Int J Gynaecol Obstet . 2019;147(1):29–35. doi:10.1002/ijgo.12888 31206641
   PubMed Web of Science ®Google Scholar
• Yu G , Hu J . Drug-eluting beads bronchial arterial chemoembolization as a neoadjuvant treatment for squamous non-small cell lung cancer. Postgrad Med . 2020;132(6):568–571. doi:10.1080/00325481.2020.1761711 32400251
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA , Therasse P , Bogaerts J , et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer . 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.026 19097774
   PubMed Web of Science ®Google Scholar
• Aaronson NK , Ahmedzai S , Bergman B , et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst . 1993;85(5):365–376. doi:10.1093/jnci/85.5.365 8433390
   PubMed Web of Science ®Google Scholar
• Dingemans AM , Witlox MA , Stallaert RA , van der Valk P , Postmus PE , Giaccone G . Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res . 1999;5(8):2048–2058.10473085
   PubMed Web of Science ®Google Scholar
• Sohn JW , Lee SY , Lee SJ , et al. MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. Jpn J Clin Oncol . 2006;36(3):137–141. doi:10.1093/jjco/hyi231 16478794
   PubMed Web of Science ®Google Scholar
• Gemba K , Ueoka H , Kiura K , Tabata M , Harada M . Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome. Lung Cancer . 2000;29(1):23–31. doi:10.1016/S0169-5002(00)00098-2 10880844
   PubMed Web of Science ®Google Scholar
• Gardner EE , Lok BH , Schneeberger VE , et al. Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis. Cancer Cell . 2017;31(2):286–299. doi:10.1016/j.ccell.2017.01.006 28196596
   PubMed Web of Science ®Google Scholar
• Qiu Z , Zhu W , Meng H , et al. CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter. Theranostics . 2019;9(16):4717–4729. doi:10.7150/thno.33680 31367252
   PubMed Web of Science ®Google Scholar
• Zeng F , Wang Q , Wang S , et al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene . 2020;39(2):293–307. doi:10.1038/s41388-019-0984-2 31477834
   PubMed Web of Science ®Google Scholar
• Wang Z , Niu H , Li Z , et al. Superselective arterial embolization with drug-loaded microspheres for the treatment of unresectable breast cancer. Gland Surg . 2019;8(6):740–747. doi:10.21037/gs.2019.12.06 32042682
   PubMed Web of Science ®Google Scholar
• Vogl TJ , Lehnert T , Zangos S , et al. Transpulmonary chemoembolization (TPCE) as a treatment for unresectable lung metastases. Eur Radiol . 2008;18(11):2449–2455. doi:10.1007/s00330-008-1056-0 18553086
   PubMed Web of Science ®Google Scholar
• Baylatry MT , Pelage JP , Wassef M , et al. Pulmonary artery chemoembolization in a sheep model: evaluation of performance and safety of irinotecan eluting beads (DEB-IRI). J Biomed Mater Res B Appl Biomater . 2011;98(2):351–359. doi:10.1002/jbm.b.31858 21656666
   PubMed Web of Science ®Google Scholar
• Shang B , Li J , Wang X , et al. Clinical effect of bronchial arterial infusion chemotherapy and CalliSpheres drug-eluting beads in patients with stage II-IV lung cancer: a prospective cohort study. Thorac Cancer . 2020;11(8):2155–2162. doi:10.1111/1759-7714.13522 32603550
   PubMed Web of Science ®Google Scholar
• Zhou M , Wang Z , Yao Y , Zhou H , Liu M , Sun J . Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer. Clin Transl Oncol . 2017;19(7):865–873. doi:10.1007/s12094-017-1617-2 28127669
   PubMed Web of Science ®Google Scholar
• Huang Z , Xu D , Zhang F , Ying Y , Song L . Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer. Clin Transl Oncol . 2016;18(10):1019–1025. doi:10.1007/s12094-015-1479-4 26886220
   PubMed Web of Science ®Google Scholar